Clinical and Molecular Hepatology10.3350/cmh.2018.10062018243299-301Combination of synbiotic and sitagliptin in nonalcoholic fatty liver disease: Is it better than sitagliptin alone?Yong Kyun Cho,,
Clinical and Molecular Hepatology10.3350/cmh.2018.00062018243331-338Combined effects of synbiotic and sitagliptin versus sitagliptin alone in patients with nonalcoholic fatty liver diseaseSaba Sayari, Hassan Neishaboori, Maryam Jameshorani,,
Hepatology International10.1007/s12072-015-9625-1201594481-483Two are better than one: noninvasive assessment of liver fibrosis in nonalcoholic fatty liver diseaseGrace Lai-Hung Wong, Henry Lik-Yuen Chan,,
Clinical Liver Disease10.1002/cld.65201214104-107Nonalcoholic fatty liver disease: Indications for liver biopsy and noninvasive biomarkersMazen Noureddin, Rohit Loomba
Alimentary Pharmacology & Therapeutics10.1111/j.1365-2036.2007.03246.x2007258883-889GI Epidemiology: nonalcoholic fatty liver diseaseP. ANGULO
Clinical Liver Disease10.1002/cld.66201214129-130Management of nonalcoholic fatty liver disease in childrenJean P. Molleston
Clinical Liver Disease10.1002/cld.75201214125-128Pediatric nonalcoholic fatty liver disease: Prevalence, diagnosis, risk factors, and managementStavra A. Xanthakos, Rohit Kohli
Clinical Liver Disease10.1002/cld.27201214112-113Natural history of nonalcoholic fatty liver diseaseRohini Mehta, Zobair M. Younossi
Diagnosis of Liver Disease10.1007/978-981-13-6806-6_7201975-84Alcoholic Liver Disease and Nonalcoholic Fatty Liver Disease/Nonalcoholic SteatohepatitisEtsuko Hashimoto, Masaki Iwai, Arief A. Suriawinata
Talanta10.1016/j.talanta.2011.04.0512011851673-680Liquid chromatographic determination of sitagliptin either alone or in ternary mixture with metformin and sitagliptin degradation productRamzia I. El-Bagary, Ehab F. Elkady, Bassam M. Ayoub,